Thalamic LFPs and VIM DBS in Essential Tremor: Correlation, Evolution, and Therapeutic Perspectives
VIM-CLT
1 other identifier
interventional
12
1 country
1
Brief Summary
The objective of this study is to characterize through spectral analysis intra-thalamic local field potentials (LFPs) recorded through implanted DBS leads during periods with and without tremor in patients suffering from severe essential tremor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2014
CompletedFirst Posted
Study publicly available on registry
October 15, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2020
CompletedAugust 13, 2021
August 1, 2021
6.1 years
June 20, 2014
August 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
LFPs records 3 month after implantation
in order to characterize the features of tremor-related thalamic activity during the initiation of movement-related tremor-induced activity
3 month after implantation
LFPs records 12 month after implantation
in order to characterize the features of tremor-related thalamic activity during the initiation of movement-related tremor-induced activity
12 month after implantation
Study Arms (1)
Deep Brain Stimulation
EXPERIMENTALAll of included patients will receive a standard deep brain stimulation of the thalamus in order to reduce their essential tremor
Interventions
Deep Brain Stimulation of VIM.
Eligibility Criteria
You may qualify if:
- Patients suffering from severe and disabling ET with serious impact on their quality of life (QoL).
- years old
- Free of evolutive and untreated psychiatric disorder
- Tremor must be predominant in the upper limbs although it can affect the lower limbs, head and voice.
- Affiliation to a social security system
- Written informed consent signed by the participant and the investigator (prior to any examination required by research)
You may not qualify if:
- Parkinsonian tremor
- Pregnancy or lactating women
- Severe co-morbidity (cardiac, renal or respiratory failures, evolutive cancer)
- Impaired cognitive functions (score \<130 on Mattis scale).
- Patients with severe atrophy or lesions on MRI
- Depression (Beck \> 10)
- Participation in another clinical research for 18 months (after surgery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Bordeauxlead
- APTES 100 rue boileau 69006 Lyoncollaborator
Study Sites (1)
University Hospital Bordeaux, France
Bordeaux, 33076, France
Related Publications (10)
Barbe MT, Liebhart L, Runge M, Pauls KA, Wojtecki L, Schnitzler A, Allert N, Fink GR, Sturm V, Maarouf M, Timmermann L. Deep brain stimulation in the nucleus ventralis intermedius in patients with essential tremor: habituation of tremor suppression. J Neurol. 2011 Mar;258(3):434-9. doi: 10.1007/s00415-010-5773-3. Epub 2010 Oct 8.
PMID: 20927533BACKGROUNDBenabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1-6):344-6. doi: 10.1159/000100803.
PMID: 3329873BACKGROUNDBlomstedt P, Hariz GM, Hariz MI, Koskinen LO. Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up. Br J Neurosurg. 2007 Oct;21(5):504-9. doi: 10.1080/02688690701552278.
PMID: 17922323BACKGROUNDBrown P, Williams D. Basal ganglia local field potential activity: character and functional significance in the human. Clin Neurophysiol. 2005 Nov;116(11):2510-9. doi: 10.1016/j.clinph.2005.05.009. Epub 2005 Jul 18.
PMID: 16029963BACKGROUNDGarcia Ruiz P, Muniz de Igneson J, Lopez Ferro O, Martin C, Magarinos Ascone C. Deep brain stimulation holidays in essential tremor. J Neurol. 2001 Aug;248(8):725-6. doi: 10.1007/s004150170127. No abstract available.
PMID: 11569910BACKGROUNDHariz MI, Shamsgovara P, Johansson F, Hariz G, Fodstad H. Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. Stereotact Funct Neurosurg. 1999;72(2-4):208-18. doi: 10.1159/000029728.
PMID: 10853080BACKGROUNDLimousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry. 1999 Mar;66(3):289-96. doi: 10.1136/jnnp.66.3.289.
PMID: 10084526BACKGROUNDSchuurman PR, Bosch DA, Bossuyt PM, Bonsel GJ, van Someren EJ, de Bie RM, Merkus MP, Speelman JD. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000 Feb 17;342(7):461-8. doi: 10.1056/NEJM200002173420703.
PMID: 10675426BACKGROUNDStacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J; TRS study group. Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Mov Disord. 2007 Apr 30;22(6):833-8. doi: 10.1002/mds.21412.
PMID: 17343274BACKGROUNDYoshida F, Martinez-Torres I, Pogosyan A, Holl E, Petersen E, Chen CC, Foltynie T, Limousin P, Zrinzo LU, Hariz MI, Brown P. Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):885-9. doi: 10.1136/jnnp.2009.190918. Epub 2010 May 12.
PMID: 20466699BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
BURBAUD Pierre, MD-PhD
University Hospital Bordeaux, France
- STUDY CHAIR
Nicolas LANGBOUR, PhD
IMN CNRS UMR 5293, Université Bordeaux 2 Segalen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2014
First Posted
October 15, 2014
Study Start
November 1, 2014
Primary Completion
November 19, 2020
Study Completion
November 19, 2020
Last Updated
August 13, 2021
Record last verified: 2021-08